{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "20124983", "DateCompleted": {"Year": "2010", "Month": "03", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1097/ALN.0b013e3181cded1f"], "ArticleDate": [], "Journal": {"ISSN": "1528-1175", "JournalIssue": {"Volume": "112", "Issue": "3", "PubDate": {"Year": "2010", "Month": "Mar"}}, "Title": "Anesthesiology", "ISOAbbreviation": "Anesthesiology"}, "ArticleTitle": "Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin- and heat shock protein 90-mediated mechanisms.", "Pagination": {"StartPage": "576", "EndPage": "585", "MedlinePgn": "576-85"}, "Abstract": {"AbstractText": ["Endothelial nitric oxide synthase activity is regulated by (6R-)5,6,7,8-tetrahydrobiopterin (BH4) and heat shock protein 90. The authors tested the hypothesis that hyperglycemia abolishes anesthetic preconditioning (APC) through BH4- and heat shock protein 90-dependent pathways.", "Myocardial infarct size was measured in rabbits in the absence or presence of APC (30 min of isoflurane), with or without hyperglycemia, and in the presence or absence of the BH4 precursor sepiapterin. Isoflurane-dependent nitric oxide production was measured (ozone chemiluminescence) in human coronary artery endothelial cells cultured in normal (5.5 mm) or high (20 mm) glucose conditions, with or without sepiapterin (10 or 100 microm).", "APC decreased myocardial infarct size compared with control experiments (26 +/- 6% vs. 46 +/- 3%, respectively; P < 0.05), and this action was blocked by hyperglycemia (43 +/- 4%). Sepiapterin alone had no effect on infarct size (46 +/- 3%) but restored APC during hyperglycemia (21 +/- 3%). The beneficial actions of sepiapterin to restore APC were blocked by the nitric oxide synthase inhibitor N (G)-nitro-L-arginine methyl ester (47 +/- 2%) and the BH4 synthesis inhibitor N-acetylserotonin (46 +/- 3%). Isoflurane increased nitric oxide production to 177 +/- 13% of baseline, and this action was attenuated by high glucose concentrations (125 +/- 6%). Isoflurane increased, whereas high glucose attenuated intracellular BH4/7,8-dihydrobiopterin (BH2) (high performance liquid chromatography), heat shock protein 90-endothelial nitric oxide synthase colocalization (confocal microscopy) and endothelial nitric oxide synthase activation (immunoblotting). Sepiapterin increased BH4/BH2 and dose-dependently restored nitric oxide production during hyperglycemic conditions (149 +/- 12% and 175 +/- 9%; 10 and 100 microm, respectively).", "The results indicate that tetrahydrobiopterin and heat shock protein 90-regulated endothelial nitric oxide synthase activity play a central role in cardioprotection that is favorably modulated by volatile anesthetics and dysregulated by hyperglycemia. Enhancing the production of BH4 may represent a potential therapeutic strategy."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA."}], "Identifier": [], "LastName": "Amour", "ForeName": "Julien", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Brzezinska", "ForeName": "Anna K", "Initials": "AK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jager", "ForeName": "Zachary", "Initials": "Z"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sullivan", "ForeName": "Corbin", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Weihrauch", "ForeName": "Dorothee", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Du", "ForeName": "Jianhai", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Vladic", "ForeName": "Nikolina", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shi", "ForeName": "Yang", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Warltier", "ForeName": "David C", "Initials": "DC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pratt", "ForeName": "Phillip F", "Initials": "PF", "Suffix": "Jr"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kersten", "ForeName": "Judy R", "Initials": "JR"}], "GrantList": [{"GrantID": "R01 HL063705-09", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P01 GM066730", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "P01 GM066730-070006", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL063705", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL089779", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Anesthesiology", "NlmUniqueID": "1300217", "ISSNLinking": "0003-3022"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anesthetics"}, {"RegistryNumber": "0", "NameOfSubstance": "HSP90 Heat-Shock Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Pterins"}, {"RegistryNumber": "0", "NameOfSubstance": "Biopterins"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "CJQ26KO7HP", "NameOfSubstance": "sepiapterin"}, {"RegistryNumber": "CYS9AKD70P", "NameOfSubstance": "Isoflurane"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type III"}, {"RegistryNumber": "EGX657432I", "NameOfSubstance": "sapropterin"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anesthetics"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["analogs & derivatives", "physiology"], "DescriptorName": "Biopterins"}, {"QualifierName": [], "DescriptorName": "Blotting, Western"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["cytology", "drug effects"], "DescriptorName": "Coronary Vessels"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Endothelial Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Enzyme Activation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glucose"}, {"QualifierName": ["physiology"], "DescriptorName": "HSP90 Heat-Shock Proteins"}, {"QualifierName": ["physiology"], "DescriptorName": "Hemodynamics"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["enzymology"], "DescriptorName": "Hyperglycemia"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ischemic Preconditioning, Myocardial"}, {"QualifierName": ["toxicity"], "DescriptorName": "Isoflurane"}, {"QualifierName": [], "DescriptorName": "Luminescence"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Microscopy, Confocal"}, {"QualifierName": ["analysis", "metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type III"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pterins"}, {"QualifierName": [], "DescriptorName": "Rabbits"}, {"QualifierName": ["drug effects"], "DescriptorName": "Ventricular Function, Left"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Amour J, Brzezinska AK, Weihrauch D, Billstrom AR, Zielonka J, Krolikowski JG, Bienengraeber MW, Warltier DC, Pratt PF, Jr, Kersten JR. Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology. 2009;110:317\u2013325.", "ArticleIdList": ["PMC2730207", "19194158"]}, {"Citation": "Gu W, Kehl F, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism. Anesthesiology. 2008;108:634\u2013642.", "ArticleIdList": ["PMC4378683", "18362595"]}, {"Citation": "Chiari PC, Bienengraeber MW, Weihrauch D, Krolikowski JG, Kersten JR, Warltier DC, Pagel PS. Role of endothelial nitric oxide synthase as a trigger and mediator of isoflurane-induced delayed preconditioning in rabbit myocardium. Anesthesiology. 2005;103:74\u201383.", "ArticleIdList": ["15983459"]}, {"Citation": "Burwell LS, Brookes PS. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid Redox Signal. 2008;10:579\u2013599.", "ArticleIdList": ["18052718"]}, {"Citation": "McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain \"calcium-independent\" eNOS activation by phosphorylation. J Biol Chem. 2000;275:6123\u20136128.", "ArticleIdList": ["10692402"]}, {"Citation": "Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation. 1997;95:1783\u20131790.", "ArticleIdList": ["9107164"]}, {"Citation": "Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Jr, Sowers JR. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134\u20131146.", "ArticleIdList": ["10477542"]}, {"Citation": "Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR. N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia. Anesthesiology. 2003;98:1384\u20131390.", "ArticleIdList": ["12766647"]}, {"Citation": "Pritchard KA, Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, Sessa WC. Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem. 2001;276:17621\u201317624.", "ArticleIdList": ["11278264"]}, {"Citation": "Chen JX, Lawrence ML, Cunningham G, Christman BW, Meyrick B. HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium. J Appl Physiol. 2004;96:612\u2013620.", "ArticleIdList": ["14555685"]}, {"Citation": "Chen JX, Meyrick B. Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium. Lab Invest. 2004;84:182\u2013190.", "ArticleIdList": ["14661033"]}, {"Citation": "Lei H, Venkatakrishnan A, Yu S, Kazlauskas A. Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J Biol Chem. 2007;282:9364\u20139371.", "ArticleIdList": ["17202141"]}, {"Citation": "Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol. 2005;288:F1144\u2013F1152.", "ArticleIdList": ["15687247"]}, {"Citation": "Ihlemann N, Rask-Madsen C, Perner A, Dominguez H, Hermann T, Kober L, Torp-Pedersen C. Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects. Am J Physiol Heart Circ Physiol. 2003;285:H875\u2013H882.", "ArticleIdList": ["12730050"]}, {"Citation": "Bagi Z, Toth E, Koller A, Kaley G. Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4) Am J Physiol Heart Circ Physiol. 2004;287:H626\u2013H633.", "ArticleIdList": ["15044190"]}, {"Citation": "Heitzer T, Krohn K, Albers S, Meinertz T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia. 2000;43:1435\u20131438.", "ArticleIdList": ["11126415"]}, {"Citation": "Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR. Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol. 2003;140:701\u2013706.", "ArticleIdList": ["PMC1574066", "14534153"]}, {"Citation": "Cosentino F, Hurlimann D, Delli Gatti C, Chenevard R, Blau N, Alp NJ, Channon KM, Eto M, Lerch P, Enseleit F, Ruschitzka F, Volpe M, Luscher TF, Noll G. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart. 2008;94:487\u2013492.", "ArticleIdList": ["17916662"]}, {"Citation": "Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart. 2002;87:264\u2013269.", "ArticleIdList": ["PMC1767023", "11847169"]}, {"Citation": "Chiari PC, Pagel PS, Tanaka K, Krolikowski JG, Ludwig LM, Trillo RA, Jr, Puri N, Kersten JR, Warltier DC. Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits. Anesthesiology. 2004;101:1160\u20131166.", "ArticleIdList": ["15505452"]}, {"Citation": "Qu XW, Thaete LG, Rozenfeld RA, Zhu Y, De Plaen IG, Caplan MS, Hsueh W. Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase. Crit Care Med. 2005;33:1050\u20131056.", "ArticleIdList": ["PMC1568387", "15891335"]}, {"Citation": "Tang XL, Takano H, Xuan YT, Sato H, Kodani E, Dawn B, Zhu Y, Shirk G, Wu WJ, Bolli R. Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits. Circulation. 2005;112:2149\u20132156.", "ArticleIdList": ["PMC3671759", "16186416"]}, {"Citation": "Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF, Jr, Kersten JR, Pagel PS, Warltier DC. Mechanism of preconditioning by isoflurane in rabbits: A direct role for reactive oxygen species. Anesthesiology. 2002;97:1485\u20131490.", "ArticleIdList": ["12459675"]}, {"Citation": "Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601\u2013605.", "ArticleIdList": ["10376603"]}, {"Citation": "Sessa WC, Garcia-Cardena G, Liu J, Keh A, Pollock JS, Bradley J, Thiru S, Braverman IM, Desai KM. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem. 1995;270:17641\u201317644.", "ArticleIdList": ["7543089"]}, {"Citation": "Whitsett J, Picklo MJS, Vasquez-Vivar J. 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol. 2007;27:2340\u20132347.", "ArticleIdList": ["17872449"]}, {"Citation": "Crabtree MJ, Smith CL, Lam G, Goligorsky MS, Gross SS. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol. 2008;294:H1530\u2013H1540.", "ArticleIdList": ["PMC2722919", "18192221"]}, {"Citation": "Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363\u2013368.", "ArticleIdList": ["15668353"]}, {"Citation": "Alp NJ, Mussa S, Khoo J, Cai S, Guzik T, Jefferson A, Goh N, Rockett KA, Channon KM. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest. 2003;112:725\u2013735.", "ArticleIdList": ["PMC182196", "12952921"]}, {"Citation": "Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal. 2008;10:1115\u20131126.", "ArticleIdList": ["18321209"]}, {"Citation": "Blackwell KA, Sorenson JP, Richardson DM, Smith LA, Suda O, Nath K, Katusic ZS. Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol. 2004;287:H2448\u2013H2453.", "ArticleIdList": ["15319209"]}, {"Citation": "Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T, Munzel T. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: Evidence for a dysfunctional nitric oxide synthase. Circ Res. 2000;86:E36\u2013E41.", "ArticleIdList": ["10666424"]}, {"Citation": "Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2002;96:183\u2013188.", "ArticleIdList": ["11753019"]}, {"Citation": "Kersten JR, Montgomery MW, Ghassemi T, Gross ER, Toller WG, Pagel PS, Warltier DC. Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol. 2001;280:H1744\u2013H1750.", "ArticleIdList": ["11247788"]}, {"Citation": "Bevers LM, Braam B, Post JA, van Zonneveld AJ, Rabelink TJ, Koomans HA, Verhaar MC, Joles JA. Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension. 2006;47:87\u201394.", "ArticleIdList": ["16344367"]}, {"Citation": "Forstermann U. Janus-faced role of endothelial NO synthase in vascular disease: Uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem. 2006;387:1521\u20131533.", "ArticleIdList": ["17132097"]}, {"Citation": "Whitsett J, Martasek P, Zhao H, Schauer DW, Hatakeyama K, Kalyanaraman B, Vasquez-Vivar J. Endothelial cell superoxide anion radical generation is not dependent on endothelial nitric oxide synthase-serine 1179 phosphorylation and endothelial nitric oxide synthase dimer/monomer distribution. Free Radic Biol Med. 2006;40:2056\u20132068.", "ArticleIdList": ["16716906"]}, {"Citation": "Wever RM, Luscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 1998;97:108\u2013112.", "ArticleIdList": ["9443438"]}, {"Citation": "Milstien S, Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function. Biochem Biophys Res Commun. 1999;263:681\u2013684.", "ArticleIdList": ["10512739"]}, {"Citation": "Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: Implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 2001;103:1282\u20131288.", "ArticleIdList": ["11238274"]}, {"Citation": "Bagi Z, Koller A. Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. J Vasc Res. 2003;40:47\u201357.", "ArticleIdList": ["12644725"]}, {"Citation": "Cai S, Khoo J, Channon KM. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc Res. 2005;65:823\u2013831.", "ArticleIdList": ["15721862"]}, {"Citation": "Shi W, Meininger CJ, Haynes TE, Hatakeyama K, Wu G. Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells. Cell Biochem Biophys. 2004;41:415\u2013434.", "ArticleIdList": ["15509890"]}, {"Citation": "Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G, Zweier JL. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci U S A. 2007;104:15081\u201315086.", "ArticleIdList": ["PMC1986616", "17848522"]}, {"Citation": "Verma S, Maitland A, Weisel RD, Fedak PW, Pomroy NC, Li SH, Mickle DA, Li RK, Rao V. Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation. J Thorac Cardiovasc Surg. 2002;123:1074\u20131083.", "ArticleIdList": ["12063453"]}, {"Citation": "Sasaki N, Yamashita T, Takaya T, Shinohara M, Shiraki R, Takeda M, Emoto N, Fukatsu A, Hayashi T, Ikemoto K, Nomura T, Yokoyama M, Hirata K, Kawashima S. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus. Arterioscler Thromb Vasc Biol. 2008;28:1068\u20131076.", "ArticleIdList": ["18403727"]}, {"Citation": "Ding QF, Hayashi T, Packiasamy AR, Miyazaki A, Fukatsu A, Shiraishi H, Nomura T, Iguchi A. The effect of high glucose on NO and O2-through endothelial GTPCH1 and NADPH oxidase. Life Sci. 2004;75:3185\u20133194.", "ArticleIdList": ["15488897"]}, {"Citation": "Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Harter L, Keel M, Meier T, Zaugg M. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology. 2007;106:262\u2013268.", "ArticleIdList": ["17264719"]}]}], "History": [{"Year": "2010", "Month": "2", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "2", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20124983", "NIHMS198576", "PMC2888104", "10.1097/ALN.0b013e3181cded1f"]}}], "PubmedBookArticle": []}